MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1053/j.ajkd.2014.09.021

Медицинская библиотека · American journal of kidney diseases : the official journal of the National Kidney Foundation · 2014

Treatment of hyponatremic encephalopathy with a 3% sodium chloride protocol: a case series.

Ayus Juan Carlos, Caputo Daniel, Bazerque Fernando, Heguilen Ricardo, Gonzalez Claudio D, Moritz Michael L

СтатьяПеревод в очереди

Аннотация

BACKGROUND

3% sodium chloride solution is the accepted treatment for hyponatremic encephalopathy, but evidence-based guidelines for its use are lacking.

STUDY

DESIGN

A case series.

SETTING &

PARTICIPANTS

Adult patients presenting to the emergency department of a university hospital with hyponatremic encephalopathy, defined as serum sodium level < 130 mEq/L with neurologic symptoms of increased intracranial pressure without other apparent cause, and treated with a continuous infusion of 500mL of 3% sodium chloride solution over 6 hours through a peripheral vein.

PREDICTORS: Hyponatremic encephalopathy defined as serum sodium level < 130 mEq/L with neurologic symptoms of increased intracranial pressure without other apparent cause.

OUTCOMES: Change in serum sodium level within 48 hours, improvement in neurologic symptoms, and clinical evidence of cerebral demyelination, permanent neurologic injury, or death within 6 months' posttreatment follow-up.

RESULTS

There were 71 episodes of hyponatremic encephalopathy in 64 individuals. Comorbid conditions were present in 86% of individuals. Baseline mean serum sodium level was 114.1±0.8 (SEM) mEq/L and increased to 117.9±1.3, 121.2±1.2, 123.9±1.0, and 128.3±0.8 mEq/L at 3, 12, 24, and 48 hours following the initiation of 3% sodium chloride solution treatment, respectively. There was a marked improvement in central nervous system symptoms within hours of therapy in 69 of 71 (97%) episodes. There were 12 deaths, all of which occurred following the resolution of hyponatremic encephalopathy and were related to comorbid conditions, with 75% of deaths related to sepsis. No patient developed neurologic symptoms consistent with cerebral demyelination at any point during the 6-month follow-up period.

LIMITATIONS: Lack of a comparison group and follow-up neuroimaging studies. Number of cases is too small to provide definitive assessment of the safety of this protocol.

CONCLUSIONS

3% sodium chloride solution was effective in reversing the symptoms of hyponatremic encephalopathy in the emergency department without producing neurologic injury related to cerebral demyelination on long-term follow-up in this case series.

Для цитирования: Ayus Juan Carlos, Caputo Daniel, Bazerque Fernando, Heguilen Ricardo, Gonzalez Claudio D, Moritz Michael L. Treatment of hyponatremic encephalopathy with a 3% sodium chloride protocol: a case series.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2014. DOI: 10.1053/j.ajkd.2014.09.021.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.